Ad
related to: novorapid warnings- Patient Coverage
With co-pay options available
Search for patient coverage.
- Safety Data
Safety Info & Side Effects Data For
US Healthcare Professionals.
- Clinical Data
Clinical Trial Data Presented For
US Healthcare Professionals.
- Dosing Data
Dosing Considerations And Data For
US Healthcare Professionals.
- Patient Coverage
Search results
Results from the WOW.Com Content Network
Insulin aspart, sold under the brand name NovoLog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [17] It is generally used by injection under the skin but may also be used by injection into a vein. [17]
Novo Nordisk created "aspart" and marketed it as NovoLog/NovoRapid (UK-CAN) as a rapid-acting insulin analogue. It was created through recombinant DNA technology so that the amino acid, B28, which is normally proline , is substituted with an aspartic acid residue.
As a medication, insulin is any pharmaceutical preparation of the protein hormone insulin that is used to treat high blood glucose. [6] Such conditions include type 1 diabetes, type 2 diabetes, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. [6]
In addition to embryo-fetal toxicity, lenalidomide carries black box warnings for hematologic toxicity (including neutropenia and thrombocytopenia) and thromboembolism. [6] Serious side effects include thrombosis , pulmonary embolus , hepatotoxicity , and bone marrow toxicity resulting in neutropenia and thrombocytopenia.
In the United States, a boxed warning (sometimes "black box warning", colloquially) is a type of warning that appears near the beginning of the package insert for certain prescription drugs, so called because the U.S. Food and Drug Administration specifies that it is formatted with a 'box' or border around the text [1] to emphasize its ...
Insulin is a peptide hormone containing two chains cross-linked by disulfide bridges. Insulin (/ ˈ ɪ n. sj ʊ. l ɪ n /, [5] [6] from Latin insula, 'island') is a peptide hormone produced by beta cells of the pancreatic islets encoded in humans by the insulin (INS) gene.
Former logo. Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark [3] with production facilities in nine countries and affiliates or offices in five countries.
Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. [1] [2] It is regarded as a second-line option compared to metformin, due to metformin's well-established safety and efficacy. [1]
Ad
related to: novorapid warnings